This module will consider and make recommendations on a range of issues relating to the development of Covid-19 vaccines and the implementation of the vaccine rollout programme in England, Wales, Scotland and Northern Ireland. Issues relating to the treatment of Covid-19 through both existing and new medications will be examined in parallel. There will be a focus on lessons learned and preparedness for the next pandemic.
Thematic issues relating to unequal vaccine uptake will be examined, to include the identification of groups which were the subject of unequal uptake, potential causes of such unequal uptake and the Government response.
The module will address issues of recent public concern relating to vaccine safety and the current system for financial redress under the UK Vaccine Damage Payment Scheme.
The application process to become a Core Participant for Module 4 has now closed.
The Inquiry plans to hear evidence for this investigation in London across three weeks.
-
- Tue 14 – Thu 30 Jan 2025
Upcoming or past hearing dates for this module can be viewed on the Inquiry’s hearings page.
Related documents
- Module 4 Provisional Outline of Scope
This document outlines the provisional scope of Module 4.
- List of Module 4 Core Participants
A List of Core Participants in Module 4 of the…